Medication info

L-Rectan Granules (L-Leucine, L-Valine, L-Isoleucine)

Prescription medication경구Approval withdrawn
Ingredient · strength
L-Isoleucine›952mg / 1 packetL-Leucine›1904mg / 1 packetL-Valine›1144mg / 1 packet
Manufacturer / importer
코오롱제약(주)
Appearance
A white granule with a slight sweetness and a lemon scent.
Packaging
4.226g/pack, 30 packs (4.226g/pack x 30), 45 packs (4.226g/pack x 45)
Approval status
Approval withdrawn

MFDS item code 200500591 · Notified 2005.12.29

This product's status changed to Approval withdrawn on 2025.03.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypoalbuminemia in non-cirrhotic liver patients.
Who takes it
Adults
Adult dose
Adults take 1 packet (4.226g) orally 3 times a day after meals.

Ingredients

Manufacturer
코오롱제약(주)

Efficacy & effects

Improvement of hypoalbuminemia in non-cirrhotic liver patients.

  • Hypoalbuminemia
View approved original text

In patients with non-cirrhotic liver disease who show hypoalbuminemia despite sufficient food intake, this medication can assist in improving hypoalbuminemia. Hypoalbuminemia is a state of low albumin levels in the blood due to impaired liver function, and improving this can enhance the overall health status of the patient. Therefore, this medication effectively improves hypoalbuminemia in patients with liver cirrhosis.

How to take

Adult dose

Adults take 1 packet (4.226g) orally 3 times a day after meals.

Precautions

This medication should not be used in patients who are genetically unable to properly metabolize certain amino acids. Administration in such patients may cause serious side effects such as seizures or difficulty in breathing. During the course of taking this medication, gastrointestinal symptoms such as constipation, diarrhea, abdominal bloating, abdominal discomfort, and vomiting may occasionally occur. If these symptoms appear, consider reducing the dosage or temporarily discontinuing the medication. Additionally, it may sometimes affect kidney function and increase blood BUN levels. In such cases, it is also necessary to adjust the dosage or temporarily discontinue use. A metabolic disorder causing elevated blood ammonia levels may occur, so if such symptoms appear, the dosage should be reduced or discontinued. Due to liver dysfunction, there may be elevations in AST, ALT, and bilirubin levels, along with symptoms such as skin rashes, itching, swelling in the face or legs, and fatigue. This medication is only recommended for cirrhotic patients with low serum albumin levels who have sufficient food intake. Patients with diabetes or hepatic encephalopathy should closely monitor their food intake and receive dietary guidance as needed. Those with severe hepatic encephalopathy or significantly elevated total bilirubin levels, or those with severely reduced protein synthesis ability in the liver, should avoid this medication. As this medication contains only branched-chain amino acids, it is important to manage diet to ensure that the patient obtains sufficient protein and calories. Particularly in patients requiring protein restriction, if the minimum amount of protein and calories is not secured, the drug's effectiveness may diminish and nutritional status may worsen. Long-term use may lead to elevated BUN or ammonia levels on blood tests, so regular monitoring is necessary, and overdose may exacerbate nutritional status. If symptoms do not improve after taking for more than 2 months, alternative treatment options should be considered. Elderly patients may have decreased physiological function and be at higher risk for metabolic disorders when taking this medication, so caution is advised. The safety of this medication in pregnant or breastfeeding women has not been established; it should only be administered if the benefits outweigh the risks. The safety in children has not been confirmed, so it is advisable not to use this medication in children. This medication should be stored out of reach of children, and transferring it to another container should be avoided as it may pose a risk of accidents and reduce quality.

Side effects and when to seek care immediately

Serious side effects

Kidney dysfunction, elevated BUN, severe swelling (including face and limbs).

Mild side effects

  • Constipation
  • diarrhea
  • abdominal bloating
  • abdominal discomfort
  • nausea
  • vomiting
  • loss of appetite
  • epigastric pain
  • thirst
  • belching
Show 10 more
  • elevated blood ammonia levels
  • increased AST (GOT)
  • increased ALT (GPT)
  • elevated bilirubin
  • rash
  • itching
  • fatigue
  • swelling (in face, limbs, etc.)
  • redness
  • facial flushing.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that blocks light and allows air circulation, ideally at room temperature between 1°C and 30°C. Storing it this way will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

A white granule with a slight sweetness and a lemon scent.

Package unit

4.226g/pack, 30 packs (4.226g/pack x 30), 45 packs (4.226g/pack x 45)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.